StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) bonds

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Regentis Biomaterials reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Regentis Biomaterials's 20-F/A for the period ended Dec 31, 2024

IssueCarrying value
October Twenty Twenty Four CLA Addendum$450.00K
Twenty Twenty Notes$900.00K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 20-F/A.

See a number that looks wrong?